Efficacy and Safety of Intra-Articular Multiple Doses of 500 µg Icatibant Including 40 mg Triamcinolone as Calibrator in a Randomized, Double-Blind, Parallel-Group, Placebo-Controlled 13-Week Multi-Centre Study in Patients With Symptomatic Knee Osteoarthritis.

Trial Profile

Efficacy and Safety of Intra-Articular Multiple Doses of 500 µg Icatibant Including 40 mg Triamcinolone as Calibrator in a Randomized, Double-Blind, Parallel-Group, Placebo-Controlled 13-Week Multi-Centre Study in Patients With Symptomatic Knee Osteoarthritis.

Completed
Phase of Trial: Phase II

Latest Information Update: 23 Feb 2017

At a glance

  • Drugs Icatibant; Triamcinolone
  • Indications Musculoskeletal pain; Osteoarthritis
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Feb 2012 Actual end date (Jul 2007) added as reported by ClinicalTrials.gov.
    • 16 Feb 2012 Actual patient number is 590 according to ClinicalTrials.gov.
    • 20 Apr 2007 Status changed from in progress to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top